Workflow
港股投资周报:港股精选组合本周上涨4.07%,年内上涨36.51%-20250607
Guoxin Securities·2025-06-07 08:29
  • The "Guosen Securities Hong Kong Stock Selection Portfolio" achieved an absolute return of 4.07% this week and an annual return of 36.51%[1][17] - The portfolio aims to select stocks with both fundamental support and technical resonance from an analyst-recommended stock pool, constructed based on analyst earnings forecast upgrades, initial coverage, and unexpected events in analyst report titles[13][15] - The backtest period for the portfolio is from January 1, 2010, to December 31, 2024, with an annualized return of 17.02% and an excess return of 17.60% relative to the Hang Seng Index[15] - The portfolio's performance metrics include an information ratio (IR) of 1.19, a tracking error of 14.45%, and a maximum drawdown of 23.73% over the entire sample period[18] - The "Stable New High Stock Selection Method" screens stocks that have reached a 250-day high in the past 20 trading days based on analyst attention, relative stock strength, price path stability, and continuity of new highs[19][21] - The specific calculation for the 250-day new high distance is given by the formula: $ 250 \text{ day new high distance} = 1 - \frac{Closet}{ts_max(Close, 250)} $ where Closet is the latest closing price and ts_max(Close, 250) is the maximum closing price in the past 250 trading days[21] - The selected stable new high stocks include companies like Cinda Biopharmaceuticals, with the consumer sector having the most stocks reaching new highs, followed by pharmaceuticals, large finance, technology, cyclical, and manufacturing sectors[21][22] - The performance metrics for the Hong Kong Stock Selection Portfolio include: - Absolute return: 4.07% (weekly), 36.51% (year-to-date) - Excess return relative to Hang Seng Index: 1.91% (weekly), 17.90% (year-to-date) - Information ratio (IR): 1.19 - Tracking error: 14.45% - Maximum drawdown: 23.73%[17][18] - The performance metrics for the stable new high stocks include: - Consumer sector: 12 stocks - Pharmaceuticals: 11 stocks - Large finance: 10 stocks - Technology: 9 stocks - Cyclical: 3 stocks - Manufacturing: 2 stocks[21][22]